BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 1587397)

  • 1. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.
    Kelley DE; Mandarino LJ
    J Clin Invest; 1990 Dec; 86(6):1999-2007. PubMed ID: 2123890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of basal insulin in maintenance of intracellular glucose metabolic pathways in non-insulin-dependent diabetes mellitus.
    Suh KI; Song YM; Murata C; Joyce M; Ditzler TM; Henry RR
    Metabolism; 1995 Jan; 44(1):41-6. PubMed ID: 7854164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus.
    Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL
    Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E898-905. PubMed ID: 8279545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
    Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
    Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
    J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
    Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
    Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate dehydrogenase activity in the rat.
    Kruszynska YT; McCormack JG; McIntyre N
    Diabetologia; 1990 Jul; 33(7):396-402. PubMed ID: 2119322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.